Marlene Seegräber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Marlene Seegräber has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Wollenberg
Department of Dermatology and Allergy, University Hospital Augsburg, Augsburg, Germany
1 shared publication - Bernhard Homey
Department of Dermatology, University Hospital Düsseldorf, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
1 shared publication Dagmar Simon
Department of Dermatology and Allergy, University of Berne, Berne, Switzerland
1 shared publication- Jens Hansen
Icahn School of Medicine at Mount Sinai
1 shared publication Lars Siim Madsen
Dermtreat Aps, Virum, Denmark
1 shared publicationMargitta Worm
Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 16 November 2019
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (5) , 1074-1079
Recurrent eczema herpeticum – a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients
Background: Eczema herpeticum (EH) is a disseminated viral infection of eczematous skin disease with the herpes simplex virus. Knowledge on clinical characteristics, risk factors and recurrent disease is limited. Our aim was to better define clinical characteristics and risk factors for EH and especially for recurrent EH.Methods: A retrospective analysis of EH cases assessed the history, clinical signs, prior treatment and laboratory results using a predefined questionnaire.Results: A total of 224 EH cases from eight European centres were included. Extrinsic AD was identified as risk factor for EH, and only one patient suffered from intrinsic AD. Early onset of AD was identified as risk factor for recurrent EH. Pretreatment with topical steroids, systemic steroids, topical calcineurin inhibitors or plain emollients reflected standard therapy. Many patients showed AD lesions without EH, but skin without AD lesions was never affected by herpetic lesions.Conclusion: Patients with clinically active, extrinsic AD are at risk of EH. Recurrent EH is associated with confounders of severe atopic distortion and requires active AD lesions for clinical manifestation. Recurrent eczema herpeticum mainly affects patients with early onset of AD.
- 16 November 2019
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (5) , 1074-1079
Open AccessRecurrent eczema herpeticum – a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients
Background: Eczema herpeticum (EH) is a disseminated viral infection of eczematous skin disease with the herpes simplex virus. Knowledge on clinical characteristics, risk factors and recurrent disease is limited. Our aim was to better define clinical characteristics and risk factors for EH and especially for recurrent EH.Methods: A retrospective analysis of EH cases assessed the history, clinical signs, prior treatment and laboratory results using a predefined questionnaire.Results: A total of 224 EH cases from eight European centres were included. Extrinsic AD was identified as risk factor for EH, and only one patient suffered from intrinsic AD. Early onset of AD was identified as risk factor for recurrent EH. Pretreatment with topical steroids, systemic steroids, topical calcineurin inhibitors or plain emollients reflected standard therapy. Many patients showed AD lesions without EH, but skin without AD lesions was never affected by herpetic lesions.Conclusion: Patients with clinically active, extrinsic AD are at risk of EH. Recurrent EH is associated with confounders of severe atopic distortion and requires active AD lesions for clinical manifestation. Recurrent eczema herpeticum mainly affects patients with early onset of AD.
- 1 October 2018
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 126 (4) , e204
The Rivelin Patch—A New Treatment Strategy for Oral Lichen Planus
- 1 October 2018
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 126 (4) , e204
The Rivelin Patch—A New Treatment Strategy for Oral Lichen Planus